UK Bioindustry Association Launches Genomics Advisory Committee
At its Committee Summit in London today, the UK Bioindustry Association (BIA) launched its new Genomics Advisory Committee to support the strategic objective that "the UK starts, scales, and builds world leading genomic businesses".
Companies and organizations represented on the Committee include Congenica, Eagle Genomics, Genomics plc, Global Gene Corp, LGC Ltd, NewGene ltd, Oxford Nanopore Technologies Ltd, and the Wellcome Sanger Institute.
The Committee will act as a leadership platform for sharing and discussing issues of common concern between genomic businesses and will provide expert advice on important issues such as the use of data and embedding genomic medicine in the NHS. It has already got off to a flying start through supporting a panel on genomics that the BIA participated with alongside partners in San Francisco in January during the 36th annual JP Morgan Healthcare Conference.
BIA Chief Executive, Steve Bates commented: “Genomic medicine is on the brink of transforming healthcare and the UK is at the forefront of this revolution. Convening this group will strengthen the voice of UK industry at an exciting and interesting time for genomics, working to ensure that the UK environment remains supportive and internationally competitive for genomic SMEs.”
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Beyond the Prescription: The Role Pharma Plays in Digital Health Conversations
April 1st 2025As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.
